Searchable abstracts of presentations at key conferences in endocrinology

ea0090rc5.2 | Rapid Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Analysis of germline mutations in patients with non-syndromic adrenocortical carcinoma

Terzolo Massimo , Grisanti Salvatore , Scatolini Maria , Tomaiuolo Pasquale , Grosso Enrico , Basile Vittoria , Cosentini Deborah , Puglisi Soraya , Lagana Marta , Perotti Paola , Rossini Elisa , Sigala Sandra , Volante Marco , Berruti Alfredo

Background: Adrenocortical carcinoma (ACC) is a rare cancer associated with hereditary syndromes in 10% of cases. However, data on germline variants (GVs) in adult patients with sporadic ACC are limited.Methods: We analyzed germline DNA from 150 adult patients with sporadic ACC sequentially referred to our centers between 1998-2019. We designed a custom panel of 17 genes potentially involved in the pathogenesis of ACC: AIP, APC, ARMC5, ARNT, BRCA1, BRCA2...

ea0093oc17 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

Preclinical and clinical evidence of progesterone/megestrol acetate activity in metastatic adrenocortical carcinoma

Tamburello Mariangela , Abate Andrea , Turla Antonella , Lagana Marta , Rossini Elisa , Hantel Constanze , Tiberio Guido Alberto Massimo , Cosentini Deborah , Grisanti Salvatore , Berruti Alfredo , Sigala Sandra

Background: Adrenocortical carcinoma (ACC) is a rare cancer for which available systemic treatments, mitotane ± etoposide, doxorubicin and cisplatin (EDP-M), have limited efficacy.Objectives: Here, we strengthen the effect of progesterone (Pg) on metastatic ACC cell lines, studying whether it could influence growth, invasiveness, and metastasis formation. Additionally, we investigate if the Pg analogue megestrol-acetate administered with EDP-M could...

ea0081oc2.6 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Activity of abiraterone acetate in the management of cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial

Puglisi Soraya , Cosentini Deborah , Grisanti Salvatore , Basile Vittoria , Lagana Marta , Ferarri VittorioDomenico , Abate Andrea , Calabrese Anna , Rossini Elisa , Perotti Paola , Saba Laura , Pia Anna , Sigala Sandra , Berruti Alfredo , Terzolo Massimo

Background: More than 50% of adrenocortical carcinomas (ACC) in adults are associated with cortisol excess that makes tumor management challenging and has a negative impact on patient outcome. Abiraterone acetate (AA) is an irreversible inhibitor of the 17α-hydroxylase/C17, 20-lyase (CYP17 enzyme) that is used in patients with prostate cancer, in whom it leads to suppression of cortisol and androgens. The aim of this study was to assess the activity of AA to control corti...

ea0099rc10.5 | Rapid Communications 10: Calcium and Bone | Part II | ECE2024

Determinants of vertebral fractures and effectiveness of anti-resorptive drmgs in pre-menopausal women with early breast cancer under hormone deprivation therapies: A multicenter real-world study

Cristofolini Giacomo , Pedersini Rebecca , Palermo Andrea , Vena Walter , Presciuttini Barbara , Birtolo Maria Francesca , Tabacco Gaia , Naciu Anda Mihaela , Pigni Stella , Lagana Marta , Mazzoleni Federica , Cosentini Deborah , Ciafardini Antea , Pagani Mauro , Farina Davide , Balzarini Luca , Zambelli Alberto , Torrisi Rosalba , Cianferotti Luisella , Napoli Nicola , Bossi Antonio Carlo , Berruti Alfredo , Lania Andrea , Mazziotti Gherardo

Management of skeletal fragility in women with early breast cancer (BC) under hormone-deprivation therapies (HDTs) may be a challenge and it is still unknown whether anti-osteoporotic therapies could be active in preventing fractures in pre-menopausal women exposed to HDTs. In this real-world, multicenter study, we evaluated the effectiveness of bone-active drmgs and determinants of vertebral fractures (VFs) in 306 pre-menopausal women (mean age 47.15±5.09, range: 30-54) wi...

ea0099p236 | Adrenal and Cardiovascular Endocrinology | ECE2024

Impact of environmental pollution on adrenocortical carcinoma in Italy

Puglisi Soraya , Calabrese Anna , Ferrau Francesco , Alessi Ylenia , Lagana Marta , Grisanti Salvatore , Ceccato Filippo , Scaroni Carla , Di Dalmazi Guido , Stigliano Antonio , Altieri Barbara , Canu Letizia , Luconi Michaela , Loli Paola , DeMartino Maria Cristina , Arvat Emanuela , Palmieri Serena , Perotti Paola , Basile Vittoria , Berchialla Paola , Berruti Alfredo , Pia Anna , Reimondo Giuseppe , Cannavo Salvatore , Terzolo Massimo

Background: Whether environmental pollution may influence adrenocortical carcinoma (ACC) development remains largely unknown. The aim of this study was to evaluate the impact of exposition to environmental pollutants on ACC presentation and prognosis in Italy.Patients and methods: A retrospective analysis was done on 500 patients affected by ACC, who were diagnosed in 12 reference centers in Italy from 1990 to 2018 and followed-up for a median of 37.5 mo...